ContextVision

ContextVision AB: Transactions made under the buy-back programme

Källa: MFN
Osäker

Sammanfattning

Händelsen är tidigare annonserad, men det går inte att bekräfta att samtliga kursdrivande uppgifter är oförändrade. Den kortsiktiga riktningen är därför osäker.

Analys

Händelsen är tidigare annonserad, men det går inte att bekräfta att samtliga kursdrivande uppgifter är oförändrade. Den kortsiktiga riktningen är därför osäker. Händelsen är tidigare annonserad, men det går inte att bekräfta att samtliga kursdrivande uppgifter är oförändrade. Den kortsiktiga riktningen är därför osäker.

Nyckeltal

Ackumulerad volym under återköpsprogrammet
1 320 785 aktier
Genomsnittligt pris per aktie (NOK)
4,7667
Total transaktionsvärde (NOK)
6 407 235,86
Antal egna aktier efter transaktioner
4 178 662
Andel egna aktier av totalt aktiekapital
5,40%
Fundamental påverkan
Neutral

Ingen ny fundamental påverkan då detta är en uppföljning av ett tidigare kommunicerat återköpsprogram.

Omfattning: otillräckligt underlag

Oslo, 6 November 2026 – On 9 September, ContextVision AB (“ContextVision” or the “Company”) announced a share buy-back programme of up to NOK 12,000,000, with a maximum of 2,000,000 shares, in the period from 10 September 2026 to 29 January 2027.

DNB Carnegie, acting under the mandate from ContextVision, has carried out the following transactions under the buy-back programme:

DateAggregated daily volume (number of shares)Weighted average share price per day (NOK)Total daily transaction value (NOK)
2026-10-2928 7644,4274128 163,75
2026-10-3022 1284,267094 178,98
2026-11-0204,3332
2026-11-0311 5084,408151 011,51
2026-11-0410 4804,399946 986,03
2026-11-0524 8494,6676115 701,91
2026-11-0618 3054,502184 358,59
Previously disclosed buy-buys under the programme (accumulated)1 204 7514,83425 886 835,07
Accumulated under the buy-back programme1 320 7854,76676 407 235,86

Following the completion of the above transactions, ContextVision owns a total of 4 178 662 of own shares, corresponding to 5,40% of ContextVision’s share capital.An overview of all transactions made under the buy-back programme that have been carried out during the abovementioned time period is attached to this report and available at www.newsweb.no.This is information that ContextVision is obliged to make public pursuant to the EU Market Abuse Regulation and that is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act. This stock exchange announcement was published by Richard Hallström, CFO, on the time and date provided.

For further information, please contact:Richard Hallström, CFOEmail: richard.hallstrom@contextvision.com About ContextVision AB: ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-11-06 17:45 CET.

AttachmentsContextVision AB: Transactions made under the buy-back programmeDetailed Overview Of Buy Back 261106

Öppna PDF